MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1457 blog entries.

Postpartum Depression and Bonding Difficulties: Different but Interrelated Problems

A mother’s emotional relationship with her baby begins during her pregnancy. The mother’s feelings about her baby, described as bonding, typically grow and intensify after the baby’s birth and become the foundation of the mother’s relationship with her child.

By |2016-08-09T12:21:31-04:00December 18th, 2013|Child Outcomes, Outcomes, Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on Postpartum Depression and Bonding Difficulties: Different but Interrelated Problems

Novel Approaches to Antidepressant-Induced Sexual Side Effects: Exercise and Acupuncture

Sexual side effects may occur in 40% to 70% of patients treated with serotonin reuptake inhibitors (SRIs) and is a common reason for poor compliance with treatment and eventual discontinuation. When sexual side effects occur, they tend to emerge early, are persistent, and rarely resolve spontaneously.  A new study, reviewed in Medscape, suggests that exercise may help to reduce sexual side effects:

By |2015-05-11T12:07:52-04:00December 10th, 2013|Antidepressants, General, Sexual Health, Treatment|Comments Off on Novel Approaches to Antidepressant-Induced Sexual Side Effects: Exercise and Acupuncture

Interpersonal Therapy Based Intervention Reduces the Risk of Postpartum Depression in Teen Mothers

Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum mood disturbance, it is possible to identify certain subgroups of women who are more vulnerable.   One such group is teen mothers, where the risk of PPD is about 25%.

By |2015-08-07T14:39:54-04:00October 30th, 2013|Postpartum Depression, Postpartum Psychiatric Disorders, Prevalence & Risk Factors, Psychotherapy|Comments Off on Interpersonal Therapy Based Intervention Reduces the Risk of Postpartum Depression in Teen Mothers

Antenatal Exposure to Depression or Anxiety Increases the Risk of Adolescent Depression

Many studies have demonstrated an increased risk for depression among the children of mothers with depression.  Exactly how this vulnerability to depression is transmitted to the child is not precisely understood.  Genetic factors clearly play an important role, but there are other important factors which contribute to the intergenerational transmission of depression.  For example, many studies have shown that postpartum depression may contribute to parenting styles which increase a child’s likelihood of developing depression later on.   While the child appears to be particularly sensitive to the effects of maternal depression during the first year of life, it appears that older children are also affected by maternal depression and are more likely to suffer from depression and other psychiatric symptoms than children with non-depressed mothers.

By |2020-11-26T08:39:58-04:00October 23rd, 2013|Anxiety Disorders, Child Outcomes, Depressive Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Antenatal Exposure to Depression or Anxiety Increases the Risk of Adolescent Depression

Do Oral Contraceptives Cause Depression?

An estimated 80% of sexually active young women in the United States use hormonal or oral contraceptives (OCs).  Clinically it is found that some women report depression or mood swings with oral contraceptives; however, many women seem to tolerate hormonal contraceptive without any effects on mood.  Despite the prevalence of OC usage, few studies have explored the association between hormonal contraceptive use and mood disturbance.

By |2016-07-13T11:30:27-04:00October 14th, 2013|Contraception, Depressive Disorders, General|Comments Off on Do Oral Contraceptives Cause Depression?

FDA Approves New Hormonal Therapy for Menopausal Symptoms

The US Food and Drug Administration (FDA) has approved a novel estrogen-based drug for women for the treatment of moderate-to-severe vasomotor symptoms and osteoporosis associated with menopause.  Duavee (Wyeth Pharmaceuticals) is a once-a-day tablet containing a combination of conjugated estrogens and bazedoxifene, an estrogen agonist/antagonist.

By |2015-08-04T12:04:14-04:00October 10th, 2013|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on FDA Approves New Hormonal Therapy for Menopausal Symptoms

Complementary and Alternative Medicine Therapies for the Treatment of Perinatal Depression: A Review

In an excellent and thoughtful review article, Kristina Deligiannidis and Marlene Freeman (from the MGH Center for Women’s Mental Health) summarize data on the efficacy of complementary and alternative medicine therapies for the treatment of perinatal depression.  This is one of the most thorough reviews on CAM and provides thoughtful, evidence-based recommendations regarding the use of these treatments for women with perinatal depression.  It is definitely worth tracking down a copy of this review, but if you can’t find it, here is a summary.

By |2015-08-05T14:29:47-04:00September 30th, 2013|Alternative & Complementary, Depressive Disorders, Postpartum Depression, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy, Treatment|Comments Off on Complementary and Alternative Medicine Therapies for the Treatment of Perinatal Depression: A Review
Go to Top